Related Experiment Video
Updated: Jun 29, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Progressive Impairment of Prepubertal Growth in Children With APECED
Viivi Saari1,2, Venla Alanko1,2, Elina Holopainen2,3
1Children's Hospital and Paediatric Research Centre, Helsinki University Hospital, Helsinki 00290, Finland.
Insights
Children with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) experience progressive growth impairment from birth through prepuberty. Risk factors like disease severity and growth hormone deficiency necessitate timely interventions for optimal height attainment.
Area of Science:
- Pediatric Endocrinology
- Genetics and Rare Diseases
- Growth and Development
Background:
- Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is associated with subnormal adult height.
- Several risk factors may contribute to suboptimal height in children with APECED.
Purpose of the Study:
- To investigate the growth patterns in children diagnosed with APECED.
- To identify factors influencing height attainment in pediatric APECED patients.
Main Methods:
- Retrospective longitudinal study of 59 children from the Finnish national APECED cohort.
- Analysis of length/height and weight z-scores from birth to the end of prepuberty.
Main Results:
- Children with APECED showed a progressive decline in height z-scores from birth to prepuberty (median z-score -1.95).
- Factors negatively correlating with final height z-score included age at prepuberty, number of APECED manifestations, glucocorticoid treatment duration, and growth hormone deficiency.
- 12% of patients were born small for gestational age, and 64% had height z-scores below 0 throughout prepuberty.
Conclusions:
- Children with APECED exhibit significant, progressive growth impairment during childhood.
- Disease severity and growth hormone deficiency are key risk factors for poor height attainment.
- Urgent need for timely interventions and novel treatment strategies to improve growth outcomes in APECED.
Context:
Subjects with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) have subnormal adult height. There are several potential APECED-related risk factors for suboptimal height attainment during childhood.
Objective:
To determine the growth patterns in children with APECED.
Methods:
This retrospective longitudinal study included 59 children with APECED from the Finnish national APECED cohort and assessed length/height and weight z-scores from birth to the end of prepuberty.
Results:
Collectively, 59 children (30 [51%] girls) were included. Their median birth weight z-score (-0.60) was below the population average; 12 (20%) patients were born small for gestational age. Height attainment progressively declined from birth until the end of prepuberty (z-score -1.95), whereas weight-for-height z-score did not (+0.26). Of the 59 patients, 38 (64%) had all height z-scores below 0 during prepuberty, and 7 (12%) had z-scores below -2.0. Age at the end of prepuberty, number of APECED manifestations, duration of glucocorticoid treatment, and growth hormone deficiency correlated negatively with height z-score at the end of prepuberty (P < .0001; P = .041; P = .013; P = .034, respectively).
Conclusion:
Children with APECED had a progressive growth impairment from birth through prepuberty. Multiple predisposing risk factors were recognized, including disease severity and growth hormone deficiency. Timely interventions are needed to ensure optimal height attainment and new treatment options need to be developed.
More Related Videos
09:36Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Information Processing Approach
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...